Thimerosal Characterization In Children Should Be Research Focus - Zoon
Executive Summary
Characterization of thimerosal's effects in vaccinated children should constitute a significant portion of immediate research, balanced with research into new types of vaccine preservatives, FDA Center for Biologics Evaluation & Research Director Kathyrn Zoon, PhD, said at the National Vaccine Advisory Committee-sponsored workshop on thimerosal in vaccines Aug. 12.